What are the responsibilities and job description for the Programmer Analyst 3 position at unm?
The CHPVP is seeking an Analyst Programmer 3 to support its operations. The CHPVP conducts public health surveillance under the New Mexico HPV Pap Registry (NMHPVPR) which is authorized under NM Notifiable Diseases and Conditions. Reporting to the NMHPVPR occurs via direct interface with national, regional and statewide laboratories and hospitals.
Under indirect supervision, the analyst programmer applies systems analysis and designs techniques to develop and maintain Oracle databases and tables and front-end client server applications in support of NMHPVPR mission-critical computing on production systems. Technically ensures quality software, reliable information, and stable applications for mission-critical NMHPVPR functions.
This position requires a highly experienced programmer with an interest and ability to think beyond a narrow set of specialized skills and a desire to apply problem-solving techniques to design and maintain comprehensive and integrated data systems and applications.
The University of New Mexico Comprehensive Cancer Center is the Official Cancer Center of New Mexico and the only National Cancer Institute-designated Cancer Center in a 500-mile radius. Its 146 board-certified oncology specialty physicians include cancer surgeons in every specialty (abdominal, thoracic, bone and soft tissue, neurosurgery, genitourinary, gynecology, and head and neck cancers), adult and pediatric hematologists/medical oncologists, gynecologic oncologists, and radiation oncologists. They, along with more than 600 other cancer healthcare professionals (nurses, pharmacists, nutritionists, navigators, psychologists and social workers), provide treatment to 65% of New Mexico’s cancer patients from all across the state and partner with community health systems statewide to provide cancer care closer to home. They treated 13,578 patients in 105,748 ambulatory clinic visits in addition to in-patient hospitalizations at UNM Hospital. A total of 1361 patients participated in cancer clinical trials, including 544 (40%) patients who participated in clinical trials testing new cancer treatments that include tests of novel cancer prevention strategies and cancer genome sequencing. The more than 102 cancer research scientists affiliated with the UNMCCC were awarded $36.2 million in federal and private grants and contracts for cancer research projects. Since 2015, they have published 930 manuscripts, and promoting economic development, they filed 136 new patents and launched 10 new biotechnology start-up companies. Finally, the physicians, scientists and staff have provided education and training experiences to more than 530 high school, undergraduate, graduate, and postdoctoral fellowship students in cancer research and cancer health care delivery. Learn more at http://cancer.unm.edu.